Literature DB >> 18516452

The role of hyperbaric oxygen therapy (hot) as an otoprotection agent against cisplatin ototoxicity.

Camila C Yassuda1, Ana Elisa M Righetti, Maria Cristina L Cury, Miguel Angelo Hyppolito, José Antonio A de Oliveira, Omar Féres.   

Abstract

PURPOSE: Hyperbaric oxygen therapy (HOT) consists of intermittent inhalations of 100% oxygen at a pressure higher than 1 atm. It is an important adjuvant therapy in pathological processes like soft tissue infections, radiation injury, gas gangrene, osteomyelitis and decompressive diseases. Cisplatin, a potent antineoplastic drug, widely used in cancer therapy is highly ototoxic causing bilateral, irreversible damage to the hearing of high frequency sounds (4-8 KHz).
OBJECTIVE: This experimental study conducted at the Faculty of Medicine of Ribeirao Preto, University of Sao Paulo aims to evaluate Hyperbaric Oxygen Therapy as an otoprotection agent against drug toxicity.
METHODS: Albino guinea pigs were divided into two groups: in Group A, 5 animals (10 cochlea) received cisplatin, i. p., 8.0 mg/kg/day during three days and afterwards were submitted to HOT; in Group B, 3 animals (6 cochlea) received cisplatin, i. p. 8.0 mg/kg/day during three days. Guinea pigs were evaluated by acoustic otoemissions (AOE) and scanning electron microscopy (SEM).
RESULTS: Group B animals showed loss of auditory functions as measured by AOE and distorted outer hair cells by SEM. In Group A, outer hair cells shown by SEM images were mostly preserved.
CONCLUSION: It is presumed that Hyperbaric Oxygen Therapy has a protector effect against cisplatin ototoxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18516452     DOI: 10.1590/s0102-86502008000700013

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  4 in total

1.  Cisplatin and cranial irradiation-related hearing loss in children.

Authors:  Rajasekharan Warrier; Aman Chauhan; Murali Davluri; Sonya L Tedesco; Joseph Nadell; Randall Craver
Journal:  Ochsner J       Date:  2012

2.  Anti-inflammatory and anti-apoptotic effects of hyperbaric oxygen preconditioning in a rat model of cisplatin-induced peripheral neuropathy.

Authors:  Emad Khademi; Vahid Pirhajati Mahabadi; Hassan Ahmadvand; Esmaeil Akbari; Ali Reza Khalatbary
Journal:  Iran J Basic Med Sci       Date:  2020-03       Impact factor: 2.699

Review 3.  Prevention and restoration of hearing loss associated with the use of cisplatin.

Authors:  Felician Chirtes; Silviu Albu
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

4.  The effects of hyperbaric oxygen therapy upon ototoxic injuries produced by amikacin in guinea pigs.

Authors:  Luciana de Albuquerque Salviano Amora; Adriana de Andrade Batista Murashima; Maria Rossato; Márcia Bento Moreira; Miguel Ângelo Hyppolito; Djalma José Fagundes
Journal:  Braz J Otorhinolaryngol       Date:  2013 May-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.